InVivo Therapeutics Holdings Corp. Stock
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 USD | -5.00% | +2.70% | -47.95% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -10M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M | Net cash position 2022 | 15.4M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | 6 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1 day | -1.96% | ||
1 week | +8.11% | ||
Current month | +8.11% | ||
1 month | +66.67% | ||
3 months | -27.18% | ||
6 months | -54.29% | ||
Current year | -45.21% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.38 | -5.00% | 1 249 |
24-05-08 | 0.4 | -1.96% | 1,350 |
24-05-07 | 0.408 | +10.27% | 3,382 |
24-05-06 | 0.37 | 0.00% | 311 |
24-05-03 | 0.37 | 0.00% | 1,424 |
Delayed Quote OTC Markets, May 08, 2024 at 10:24 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-45.21% | 1.24M | |
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
-1.52% | 62.21B | |
+4.88% | 51.01B | |
+11.59% | 51.28B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |
- Stock Market
- Equities
- NVIV Stock